What’s causing big run up of stock price of Annovis Bio? Up 134% in past month!!!

[redhawk1]

Hope Buntanetap drug is showing signs of efficacy!

[park_bear]

General market rally plus having gotten capital raise out of the way. Also run up to data announcement has been a pattern. Not predictive of actual results

[redhawk1 in reply to park_bear]

Yep, PB, good chance recent uptick in market is responsible for some of that increase. And, some of that increase on a some excessive positive news from Annovis Bio! Small biotech stocks are always just a good offer away from being purchased by one of the big players in pharma which also could have something to do with the rise in price. Today up almost 28%! Should see soon whether or not this medication is truly beneficial to those with PD. Fingers crossed it is.

[fido2 in reply to redhawk1]

This article from early december explains a bit more details that lead to the rise: finance.yahoo.com/news/anno...

[Changsha in reply to redhawk1]

I was in the trial for 6 months and had no progression of symptoms. Since stopping, my tremor has increased significantly. I bought stock and am very hopeful Buntanetap will benefit us.

[AGH_1966 in reply to Changsha]

But you could have been on the placebo. (I hope not, and I hope it is a go-er.)

[AGH_1966]

To show you the kind of scope it has then in July 2021 it rose to $119 before falling of a cliff that month when its 'much-hyped Alzheimer's treatment failed to significantly outperform a placebo in a midstage test'. Even then it took until the end of 2021 to reach the price it is at now.

[redhawk1 in reply to AGH_1966]

Small bio-tech stocks are indeed volatile and treacherous.